Page 2 - Diffuse Largeb Cell News Today

Imugene Ltd (ASX:IMU, OTC:IUGNF) has passed a major milestone for its Azer-cel cell therapy treatment with the dosing of the first patient for its Phase 1b...

The Food and Drug Administration will speed up the review of odronextamab for patients with relasped or refractory follicular lymphoma or diffuse large B-cell lymphoma.

Getting diagnosed with cancer is a scary experience. This mom shares the time her husband was diagnosed with cancer, and how it affected her family.

Expert panelists open their discussion on diffuse large B-cell lymphoma by reflecting on diagnostic strategies and the frontline treatment armamentarium.

Florida Cancer Specialists recently released a case study that outlined its role in the evolution of a first-line therapy for adult patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL) that recently received FDA approval.

A U.S. congressman said March 31 that he's been diagnosed with cancer. Rep. Dan Kildee (D-Mich.) said that ...

Rep. Dan Kildee said Friday he's headed for surgery to remove a cancerous tumor on a tonsil. He'll be out of the office for awhile, the Michigan Democrat said in a statement,...

The International Agency for Research on Cancer (Philippines) reported that in 2020 alone, 5,795 new patients were diagnosed with leukemia and 4,370 deaths in the same year.

House Oversight Committee chair James Comer led opposition to a rule amendment to allow members to work remotely for health reasons, while noting that exceptions can be made.

Investegate announcements from F. Hoffmann-La Roche Ltd, FDA grants priority review to Roche’s bispecific antibody glofitamab for people with relapsed or refractory large B-cell lymphoma